Endocan is a reliable biomarker during continuous renal replacement therapy

被引：1
|
作者：
Hureau, Maxence [1 ,2 ,3 ,4 ]
Gaudet, Alexandre [1 ,2 ,3 ,4 ]
Caires, Nathalie De Freitas [1 ,2 ,3 ,5 ]
Parmentier, Erika [1 ,2 ,3 ,4 ]
Poissy, Julien [4 ]
Duburcq, Thibault [4 ]
Lassalle, Philippe [1 ,2 ,3 ,6 ]
Mathieu, Daniel [1 ,2 ,3 ,4 ]
机构：
[1] Univ Lille, CIIL, UMR 8204, U1019, F-59000 Lille, France
[2] CNRS, UMR 8204, F-59000 Lille, France
[3] INSERM, U1019, F-59000 Lille, France
[4] CHU Lille, Hop Roger Salengro, Pole Reanimat, F-59000 Lille, France
[5] Lunginnov, 1 Rue Pr Calmette, F-59000 Lille, France
[6] Inst Pasteur, F-59000 Lille, France
来源：
CRITICAL CARE | 2019年 / 23卷 / 01期
关键词：
D O I：
10.1186/s13054-019-2585-4
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Heparin algorithm for anticoagulation during continuous renal replacement therapy
    Marlies Ostermann
    Helen Dickie
    Linda Tovey
    David Treacher
    Critical Care, 14
  • [32] Alkalemia during continuous renal replacement therapy The authors reply
    Demirjian, Sevag
    Teo, Boon Wee
    CRITICAL CARE MEDICINE, 2008, 36 (11) : 3120 - 3121
  • [33] Fluid balance management during continuous renal replacement therapy
    Prowle, John
    Mehta, Ravindra
    SEMINARS IN DIALYSIS, 2021, 34 (06) : 440 - 448
  • [34] Using imipenem and cilastatin during continuous renal replacement therapy
    Cotton, A
    Franklin, BD
    Brett, S
    Holmes, A
    PHARMACY WORLD & SCIENCE, 2005, 27 (05): : 371 - 375
  • [35] INCIDENCE OF HYPOTHERMIA DURING CONTINUOUS RENAL REPLACEMENT THERAPY (CRRT)
    LEBLANC, M
    SAKAI, K
    WRIGHT, EJ
    KOZLOWSKI, L
    PAGANINI, EP
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 545 - 545
  • [36] Predictors of Hypophosphatemia and Outcomes during Continuous Renal Replacement Therapy
    Hendrix, Rachel Jenkins
    Hastings, M. Colleen
    Samarin, Michael
    Hudson, Joanna Q.
    BLOOD PURIFICATION, 2020, 49 (06) : 700 - 707
  • [37] Heparin algorithm for anticoagulation during continuous renal replacement therapy
    Ostermann, Marlies
    Dickie, Helen
    Tovey, Linda
    Treacher, David
    CRITICAL CARE, 2010, 14 (03):
  • [38] Using Imipenem and Cilastatin During Continuous Renal Replacement Therapy
    Alison Cotton
    Bryony Dean Franklin
    Stephen Brett
    Alison Holmes
    Pharmacy World and Science, 2005, 27 : 371 - 375
  • [39] Ertapenem clearance during modeled continuous renal replacement therapy
    Stevenson, J. M.
    Patel, J. H.
    Churchwell, M. D.
    Vilay, A. M.
    Depestel, D. D.
    Soergel, F.
    Kinzig, M.
    Jakob, V.
    Mueller, B. A.
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2008, 31 (12): : 1027 - 1034
  • [40] Edoxaban pharmacokinetics during in vitro continuous renal replacement therapy
    Wenzler, Eric
    Dalton, Kaitlyn
    Andrews, Lauren
    Benken, Scott T.
    BMC NEPHROLOGY, 2024, 25 (01)
12345